Profiel
Lars Grundemar is currently the Director at Reccan Diagnostics AB.
He was previously the Chief Executive Officer at Oncorena AB and Oncorena Holding AB.
Actieve functies van Lars Grundemar
| Bedrijven | Functie | Begin |
|---|---|---|
Reccan Diagnostics AB
 Reccan Diagnostics AB Pharmaceuticals: MajorHealth Technology Reccan Diagnostics AB provides cancer diagnosis and treatment. It offers tumor specific diagnosis, prognosis, prediction, and treatment selection with tumor specific directed therapy; and provides tumor-specific biomarkers for diagnosis and treatment selection. The company was founded by Gyorgy Marko-Varga, Roland Andersson, and Daniel Ansari and is headquartered in Lund, Sweden. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Lars Grundemar
| Bedrijven | Functie | Einde |
|---|---|---|
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Algemeen Directeur | 20-06-2022 |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Reccan Diagnostics AB
Reccan Diagnostics AB Pharmaceuticals: MajorHealth Technology Reccan Diagnostics AB provides cancer diagnosis and treatment. It offers tumor specific diagnosis, prognosis, prediction, and treatment selection with tumor specific directed therapy; and provides tumor-specific biomarkers for diagnosis and treatment selection. The company was founded by Gyorgy Marko-Varga, Roland Andersson, and Daniel Ansari and is headquartered in Lund, Sweden. | Health Technology |
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
